1. Erkell, L. J., Schirrmacher, V. (1988) Cancer Res 48, 6933-6937.
2. Montgomery, A. M. P., De Clerck, Y. A., Langley, K. E., Reisfeld, R. A., Mueller, B. M. (1993) Cancer Res 53,693-700.
3. Monsky, W. L., Lin, C. Y., Aoyama, A., Kelly, T., Akiyama, S. K., Mueller, S. C., Chen, W. T. (1994) Cancer Res 54,5702-5710.
1. Leung, W.H. et al. (2013). Modulation of NKG2D ligand expression and metastasis in tumors by spironolactone via RXR{gamma} activation. J. Exp. Med. 210:2675-2692.
2. Nakayama, K. et al. (2013). cAMP-response element-binding Protein (CREB) and NF-{kappa}B transcription factors are activated during prolonged hypoxia and cooperatively regulate the induction of matrix metalloproteinase MMP1. J. Biol. Chem. 288:22584-22595.
3. Chen, Z. et al. (2012). The iron chelators Dp44mT and DFO inhibit TGF-beta-induced epithelial-mesenchymal transition via up-regulation of N-Myc downstream-regulated gene 1 (NDRG1). J.Biol.Chem. 287:17016-17028.
4. Beach, J.R. et al. (2011). Myosin II isoform switching mediates invasiveness after TGF-beta-induced epithelial-mesenchymal transition. PNAS 108:17991-17996.
5. Eckstein, N. et al. (2009). Hyperactivation of the insulin-like growth factor receptor I signaling pathway is an essential event for cisplatin resistance of ovarian cancer cells. Cancer Res. 69:2996-3003.
6. Lam, K.K.W. et al. (2009). Glycodelin-A as a modulator of trophoblast invasion. Hum. Reprod. 24:2093-2103.
7. Eckstein, N. et al. (2008). EGFR-pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells. J. Biol. Chem. 283:739-750.
8. Thal, D.R. et al. (2008). Expression or coronin-3 (coronin-1C) in diffuse gliomas is related to malignancy. J. Pathol. 214:415-424.
9. Neil, J.R. et al. (2008). Cox-2 inactivates smad signaling and enhances EMT stimulated by TGFbeta through a PGE2-dependent mechanism. Carcinogenesis 29:2227-2235.
10. Ji, H. et al. (2007). LKB1 modulates lung cancer differentiation and metastasis. Nature 448:807-810.